Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosome-binding domain 1 pseudogene 14 (HMGN1P14) is a processed pseudogene related to the HMGN1 gene family, which encodes proteins involved in chromatin structure modulation and gene regulation. While some pseudogenes, particularly within the HMGA1 and HMGN families, can regulate their parent genes through competitive endogenous RNA (ceRNA) activity and other noncoding mechanisms, there is no scientific evidence that HMGN1P14 is transcribed, functional, or implicated in human biology or disease. It is considered nonfunctional, does not code for a protein, and holds no recognized physiologic or therapeutic relevance[2][4][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosome-binding domain 1 pseudogene 14 (HMGN1P14).